Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alain Destée

Showing results (11-20 of 95) with videos related to

Pageof 10
Sort By:
Molecular Neurodegeneration|November 15, 2017
NADPH oxidases in Parkinson's disease: a systematic reviewKarim Belarbi, Elodie Cuvelier, Alain Destée, et al.
Journal of Neurology|March 12, 2004
Effects of subthalamic nucleus stimulation on parkinsonian dysarthria and speech intelligibilityMarc Rousseaux, Pierre Krystkowiak, Odile Kozlowski, et al.
Epileptic Disorders : International Epilepsy Journal with Videotape|December 24, 2002
Relationship between oscillations in the basal ganglia and synchronization of cortical activityFrançois Cassim, Etienne Labyt, David Devos, et al.
Pharmacological Research|May 12, 2009
Lipid-lowering drugs are associated with delayed onset and slower course of Parkinson's diseaseEugénie Mutez, Alain Duhamel, Luc Defebvre, et al.
Journal of Neurology|August 20, 2009
Cognitive complaints in Parkinson's disease: its relationship with objective cognitive declineKathy Dujardin, Alain Duhamel, Marie Delliaux, et al.
Brain Research|January 2, 2007
Lipid-lowering drugs in the MPTP mouse model of Parkinson's disease: fenofibrate has a neuroprotective effect, whereas bezafibrate and HMG-CoA reductase inhibitors do notAlexandre Kreisler, Patrick Gelé, Jean-François Wiart, et al.
Brain Research|June 26, 2007
The effects of serotoninergic, noradrenergic, cholinergic and dopaminergic drugs on vigilance states in MPTP-treated miceCharlotte Laloux, Philippe Derambure, Jean-Marie Jacquesson, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 26, 2009
STN versus PPN-DBS for alleviating freezing of gait: toward a frequency modulation approach?Caroline Moreau, Luc Defebvre, David Devos, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 17, 2008
Myoclonus of peripheral origin: two case reportsLouise Tyvaert, Pierre Krystkowiak, Francois Cassim, et al.
Journal of Neurology|December 14, 2004
Cognitive and SPECT characteristics predict progression of Parkinson's disease in newly diagnosed patientsKathy Dujardin, Luc Defebvre, Alain Duhamel, et al.
Pageof 10

Showing results (11-20 of 95) with videos related to

Sort By:
Pageof 10
Molecular Neurodegeneration|November 15, 2017
NADPH oxidases in Parkinson's disease: a systematic reviewKarim Belarbi, Elodie Cuvelier, Alain Destée, et al.
Journal of Neurology|March 12, 2004
Effects of subthalamic nucleus stimulation on parkinsonian dysarthria and speech intelligibilityMarc Rousseaux, Pierre Krystkowiak, Odile Kozlowski, et al.
Epileptic Disorders : International Epilepsy Journal with Videotape|December 24, 2002
Relationship between oscillations in the basal ganglia and synchronization of cortical activityFrançois Cassim, Etienne Labyt, David Devos, et al.
Pharmacological Research|May 12, 2009
Lipid-lowering drugs are associated with delayed onset and slower course of Parkinson's diseaseEugénie Mutez, Alain Duhamel, Luc Defebvre, et al.
Journal of Neurology|August 20, 2009
Cognitive complaints in Parkinson's disease: its relationship with objective cognitive declineKathy Dujardin, Alain Duhamel, Marie Delliaux, et al.
Brain Research|January 2, 2007
Lipid-lowering drugs in the MPTP mouse model of Parkinson's disease: fenofibrate has a neuroprotective effect, whereas bezafibrate and HMG-CoA reductase inhibitors do notAlexandre Kreisler, Patrick Gelé, Jean-François Wiart, et al.
Brain Research|June 26, 2007
The effects of serotoninergic, noradrenergic, cholinergic and dopaminergic drugs on vigilance states in MPTP-treated miceCharlotte Laloux, Philippe Derambure, Jean-Marie Jacquesson, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 26, 2009
STN versus PPN-DBS for alleviating freezing of gait: toward a frequency modulation approach?Caroline Moreau, Luc Defebvre, David Devos, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 17, 2008
Myoclonus of peripheral origin: two case reportsLouise Tyvaert, Pierre Krystkowiak, Francois Cassim, et al.
Journal of Neurology|December 14, 2004
Cognitive and SPECT characteristics predict progression of Parkinson's disease in newly diagnosed patientsKathy Dujardin, Luc Defebvre, Alain Duhamel, et al.
Pageof 10